Stevanato Group S.p.A (STVN) Cash from Financing Activities (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Cash from Financing Activities of -$29.2 million for Q1 2026, up 22.38% year-over-year from -$23.9 million in Q1 2025, and down 245.8% quarter-over-quarter from $20.0 million in Q4 2025.
Stevanato Group S.p.A (STVN) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Cash from Financing Activities data on file, last reported at -$29.2 million in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$29.2 million, up 22.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $37.5 million (up 2240.77% YoY), and the FY2025 annual result was $25.7 million, down 86.86% from the prior year.
- Cash from Financing Activities fell to -$29.2 million in Q1 2026 per STVN's latest filing, from $20.0 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $159.5 million in Q1 2024 and troughed at -$63.9 million in Q2 2024.
- A 5-year average of $19.9 million and a median of $8.6 million in 2023 frame the typical range for Cash from Financing Activities.
- On a YoY basis, Cash from Financing Activities climbed as much as 1747.42% in 2024 and fell as far as 131.16% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$19.0 million in 2022, then surged by 597.24% to $94.4 million in 2023, then declined by 24.92% to $70.8 million in 2024, then slumped by 71.74% to $20.0 million in 2025, then sank by 245.8% to -$29.2 million in 2026.
- Business Quant data shows STVN's Cash from Financing Activities at -$29.2 million in Q1 2026, $20.0 million in Q4 2025, and $22.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | -29.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.19 Mn |
| Mar 31, 2026 | -29.19 Mn |
| Dec 31, 2025 | 20.02 Mn |
| Dec 31, 2025 | 20.02 Mn |
| Sep 30, 2025 | 22.70 Mn |
| Sep 30, 2025 | 22.70 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Mar 31, 2025 | -37.61 Mn |
| Mar 31, 2025 | -37.61 Mn |
| Dec 31, 2024 | 70.85 Mn |
| Dec 31, 2024 | 70.85 Mn |
| Sep 30, 2024 | 32.30 Mn |
| Sep 30, 2024 | 32.30 Mn |
| Jun 30, 2024 | -63.94 Mn |
| Jun 30, 2024 | -63.94 Mn |
| Mar 31, 2024 | 159.55 Mn |
| Mar 31, 2024 | 159.55 Mn |
| Dec 31, 2023 | 94.36 Mn |
| Dec 31, 2023 | 94.36 Mn |